Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
C.M.L. van Herpen, Md, Phd
CONTACT
Lead
Radboud University Medical Center
To assess the maximum tolerated dose (MTD) and recommended phase II dose of the combination of temsirolimus and Caelyx® in patients with advanced or therapy refractory breast cancer, endometrial cancer, or ovarian cancer.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
